Published in Pediatr Infect Dis J on January 01, 2012
Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics (2013) 2.14
Is the interpretation of rapid antigen testing for respiratory syncytial virus as simple as positive or negative? Emerg Med J (2013) 2.07
Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine (2013) 1.56
Structural vaccinology starts to deliver. Nat Rev Microbiol (2012) 1.22
Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J (2014) 1.21
Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics (2012) 1.17
Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses. PLoS One (2017) 1.05
Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes. MBio (2014) 1.01
Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review. BMC Infect Dis (2012) 0.99
Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. Am J Respir Crit Care Med (2016) 0.96
Autophagy-inducing protein beclin-1 in dendritic cells regulates CD4 T cell responses and disease severity during respiratory syncytial virus infection. J Immunol (2013) 0.96
Acute bronchiolitis in infants, a review. Scand J Trauma Resusc Emerg Med (2014) 0.93
Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries. Clin Dev Immunol (2013) 0.93
Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age. PLoS One (2013) 0.91
Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012. PLoS One (2016) 0.90
Respiratory Syncytial Virus Bronchiolitis in Children up to 5 Years of Age in Spain: Epidemiology and Comorbidities: An Observational Study. Medicine (Baltimore) (2015) 0.88
Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther (2016) 0.86
Respiratory Syncytial Virus-associated hospitalization in premature infants who did not receive palivizumab prophylaxis in Italy: a retrospective analysis from the Osservatorio Study. Ital J Pediatr (2016) 0.86
RSV infection among children born moderately preterm in a community-based cohort. Eur J Pediatr (2014) 0.85
Epidemiological and clinical data of hospitalizations associated with respiratory syncytial virus infection in children under 5 years of age in Spain: FIVE multicenter study. Influenza Other Respir Viruses (2014) 0.83
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev (2017) 0.83
GS-5806 Inhibits Pre- to Postfusion Conformational Changes of the Respiratory Syncytial Virus Fusion Protein. Antimicrob Agents Chemother (2015) 0.82
Roadblocks to translational challenges on viral pathogenesis. Nat Med (2013) 0.82
Association of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysis. BMC Infect Dis (2013) 0.82
Epinephrine Improves the Efficacy of Nebulized Hypertonic Saline in Moderate Bronchiolitis: A Randomised Clinical Trial. PLoS One (2015) 0.82
Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK. BMJ Open (2016) 0.82
Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins. PLoS Pathog (2016) 0.81
Association of folic acid supplementation during pregnancy and infant bronchiolitis. Am J Epidemiol (2014) 0.81
The clinical and etiological characteristics of influenza-like illness (ILI) in outpatients in Shanghai, China, 2011 to 2013. PLoS One (2015) 0.81
Human respiratory syncytial virus non-structural protein NS1 modifies miR-24 expression via transforming growth factor-β. J Gen Virol (2015) 0.81
Respiratory syncytial virus and reactive airway disease. Curr Top Microbiol Immunol (2013) 0.80
Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus. Hum Vaccin Immunother (2013) 0.79
Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein. J Virol (2015) 0.79
Safety, tolerability, and pharmacokinetics of the respiratory syncytial virus-prefusion F-targeting monoclonal antibody with an extended half-life, MEDI8897, in healthy adults. Antimicrob Agents Chemother (2016) 0.79
Deficiency of autophagy protein Map1-LC3b mediates IL-17-dependent lung pathology during respiratory viral infection via ER stress-associated IL-1. Mucosal Immunol (2015) 0.78
Association between breast-feeding and severity of acute viral respiratory tract infection. Pediatr Infect Dis J (2014) 0.78
Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection. Vaccine (2014) 0.78
The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation. Virology (2013) 0.78
Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles. PLoS One (2015) 0.78
Respiratory Tract Infection and Risk of Hospitalization in Children with Congenital Heart Defects During Season and Off-Season: A Swedish National Study. Pediatr Cardiol (2016) 0.77
Recent advances in the management of acute bronchiolitis. F1000Prime Rep (2014) 0.77
Incidence of Hospitalization for Respiratory Syncytial Virus Infection amongst Children in Ontario, Canada: A Population-Based Study Using Validated Health Administrative Data. PLoS One (2016) 0.77
Gene Polymorphism of Toll-Like Receptors and Lung Function at Five to Seven Years of Age after Infant Bronchiolitis. PLoS One (2016) 0.77
Respiratory syncytial virus (RSV) suppression of glucocorticoid receptor phosphorylation does not account for repression of transactivation. FEBS Open Bio (2013) 0.76
Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States counties. Pediatr Infect Dis J (2012) 0.76
Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells. BMC Res Notes (2016) 0.75
Retrospective Parameter Estimation and Forecast of Respiratory Syncytial Virus in the United States. PLoS Comput Biol (2016) 0.75
Non-invasive respiratory support for infants with bronchiolitis: a national survey of practice. BMC Pediatr (2017) 0.75
Characteristics and progression of children with acute viral bronchiolitis subjected to mechanical ventilation. Rev Bras Ter Intensiva (2016) 0.75
Post-bronchiolitis wheezing is associated with toll-like receptor 9 rs187084 gene polymorphism. Sci Rep (2016) 0.75
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants. J Perinatol (2016) 0.75
Epidemiological Features of Bronchiolitis in the Pediatric Clinic of Clinical center of Sarajevo University. Mater Sociomed (2015) 0.75
Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatr Pulmonol (2016) 0.75
Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats. Hum Vaccin Immunother (2015) 0.75
Transcriptome assists prognosis of disease severity in respiratory syncytial virus infected infants. Sci Rep (2016) 0.75
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses. Nat Microbiol (2017) 0.75
Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells. Virology (2017) 0.75
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. Nat Commun (2017) 0.75
Low serum 25-hydroxyvitamin D levels and bronchiolitis severity in Spanish infants. Eur J Pediatr (2014) 0.75
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection. Vaccines (Basel) (2017) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27
Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis (2002) 6.09
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84
Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64
Human metapneumovirus infections in young and elderly adults. J Infect Dis (2003) 4.91
Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med (2013) 4.09
Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep (2004) 3.84
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35
Rhinovirus-associated hospitalizations in young children. J Infect Dis (2007) 3.35
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A (2004) 3.23
In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis (2003) 2.99
Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J Virol (2009) 2.96
Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis (2004) 2.88
Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol (2006) 2.67
Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis (2007) 2.65
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep (2003) 2.53
Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis (2011) 2.43
Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med (2011) 2.41
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics (2003) 2.36
Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis (2004) 2.35
The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis (2012) 2.34
Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol (2010) 2.29
Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol (2008) 2.10
Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children. Pediatr Infect Dis J (2005) 2.07
Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol (2011) 2.07
Detection of novel SARS-like and other coronaviruses in bats from Kenya. Emerg Infect Dis (2009) 2.04
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis (2011) 1.98
Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol (2006) 1.97
Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains. Virus Res (2003) 1.96
Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls. Pediatr Infect Dis J (2012) 1.93
Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis (2011) 1.93
Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis (2002) 1.92
Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr (2009) 1.90
Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis (2008) 1.87
Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics (2004) 1.83
GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness. J Clin Microbiol (2003) 1.83
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol (2008) 1.80
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis (2009) 1.78
Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerg Infect Dis (2002) 1.78
Skunk and raccoon rabies in the eastern United States: temporal and spatial analysis. Emerg Infect Dis (2003) 1.72
Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J (2003) 1.71
Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis (2004) 1.65
Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis (2011) 1.64
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J (2011) 1.63
Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics (2003) 1.62
Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics (2008) 1.58
Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis (2013) 1.49
Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J (2006) 1.46
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J Immunol (2006) 1.45
Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. J Gen Virol (2004) 1.44
Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J (2009) 1.36
Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J (2006) 1.35
Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J (2003) 1.35
Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J (2011) 1.34
Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. J Infect Dis (2013) 1.34
Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus. J Am Geriatr Soc (2006) 1.32
Variation in timing of respiratory syncytial virus outbreaks: lessons from national surveillance. Pediatr Infect Dis J (2007) 1.30
Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis (2006) 1.30
Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog (2008) 1.27
Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics (2011) 1.26
Kawasaki syndrome in Hawaii. Pediatr Infect Dis J (2005) 1.24
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis (2013) 1.23
Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice. J Virol (2009) 1.23
Infectious disease hospitalizations among American Indian and Alaska native infants. Pediatrics (2003) 1.23
Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice. J Infect Dis (2009) 1.22
Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus. Clin Diagn Lab Immunol (2002) 1.22
Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol (2013) 1.20
The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol (2003) 1.20
Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. J Immunol (2009) 1.14
Viral meningitis-associated hospitalizations in the United States, 1988-1999. Neuroepidemiology (2003) 1.13
All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009. Clin Infect Dis (2012) 1.12
Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis (2008) 1.12
Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis. Pediatrics (2010) 1.08
Rocky Mountain spotted fever in the United States, 1997-2002. Vector Borne Zoonotic Dis (2006) 1.08
Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008. J Infect Dis (2010) 1.08
Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice. J Gen Virol (2009) 1.07
Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol (2008) 1.06
Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Rev Vaccines (2014) 1.06
Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics (2008) 1.06
Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg Infect Dis (2007) 1.05
Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. Int J Epidemiol (2004) 1.04
Refractory status epilepticus in suspect encephalitis. Neurocrit Care (2008) 1.04
SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis (2004) 1.03
Epidemiology of cat-scratch disease hospitalizations among children in the United States. Pediatr Infect Dis J (2005) 1.02
Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination. Pediatr Infect Dis J (2007) 1.02